AVITA Medical RCEL
NASDAQ RCEL
$17.30 -0.35 (-1.98%)
At close: Nov 11, 2026 · 4:00 PM EST

AVITA Medical (RCEL) Short term Debt (2025 - 2026)

Updated

AVITA Medical (RCEL) posted Short term Debt of $46.66 million for Q2 2026.

Analysis

AVITA Medical (RCEL) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, AVITA Medical's Short term Debt came in at $42.98 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 AVITA Medical 546.49 Mn 492.41 Mn 21.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.66 Mn
Mar 31, 2026 46.14 Mn
Dec 31, 2025 42.98 Mn
Sep 30, 2025 42.45 Mn
API Access

AVITA Medical Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=RCEL&period=max&api_key=YOUR_API_KEY